133 related articles for article (PubMed ID: 32533314)
21. Effect of landiolol hydrochloride after off-pump coronary artery bypass.
Maisawa K; Yamazaki K; Ishitoya H; Shimamura Y
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):170-5. PubMed ID: 24532615
[TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, placebo-controlled, phase III study of the short-acting β1-adrenergic receptor blocker landiolol hydrochloride for coronary computed tomography angiography in Japanese patients with suspected ischemic cardiac disease.
Hirano M; Yamashina A; Hara K; Ikari Y; Jinzaki M; Iino M; Yamaguchi T; Tanimoto M; Kuribayashi S;
Clin Drug Investig; 2014 Jan; 34(1):53-62. PubMed ID: 24174275
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites.
Krumpl G; Ulč I; Trebs M; Kadlecová P; Hodisch J; Maurer G; Husch B
J Cardiovasc Pharmacol; 2018 Mar; 71(3):137-146. PubMed ID: 29112591
[TBL] [Abstract][Full Text] [Related]
24. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
[TBL] [Abstract][Full Text] [Related]
25. Landiolol, an ultra-short-acting β₁-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: prospective, multicenter, randomized, open-label study (JL-KNIGHT study).
Sakamoto A; Kitakaze M; Takamoto S; Namiki A; Kasanuki H; Hosoda S;
Circ J; 2012; 76(5):1097-101. PubMed ID: 22361918
[TBL] [Abstract][Full Text] [Related]
26. Effective Dose of Landiolol, an Ultra-Short-Acting β-Blocker, to Decrease Heart Rate During On-Pump, Beating Coronary Artery Bypass Grafting.
Kawashima S; Kurita T; Morita K; Nakajima Y
J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2195-2200. PubMed ID: 30902552
[TBL] [Abstract][Full Text] [Related]
27. Effect of postoperative landiolol administration for atrial fibrillation after off pump coronary artery bypass surgery.
Fujii M; Bessho R; Ochi M; Shimizu K; Terajima K; Takeda S
J Cardiovasc Surg (Torino); 2012 Jun; 53(3):369-74. PubMed ID: 22249647
[TBL] [Abstract][Full Text] [Related]
28. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias - Outcomes of J-Land II Study.
Ikeda T; Shiga T; Shimizu W; Kinugawa K; Sakamoto A; Nagai R; Daimon T; Oki K; Okamoto H; Yamashita T;
Circ J; 2019 Jun; 83(7):1456-1462. PubMed ID: 31118364
[TBL] [Abstract][Full Text] [Related]
30. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
[TBL] [Abstract][Full Text] [Related]
31. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
[TBL] [Abstract][Full Text] [Related]
32. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
[TBL] [Abstract][Full Text] [Related]
33. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
34. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
[TBL] [Abstract][Full Text] [Related]
35. A multicenter, open-label study of an intravenous short-acting β1-adrenergic receptor antagonist landiolol hydrochloride for coronary computed tomography angiography by 16-slice multi-detector computed tomography in Japanese patients with suspected ischemic cardiac disease.
Hirano M; Yamashina A; Hara K; Ikari Y; Jinzaki M; Iino M; Yamaguchi T; Tanimoto M; Kuribayashi S;
Drugs R D; 2014 Sep; 14(3):185-94. PubMed ID: 25091378
[TBL] [Abstract][Full Text] [Related]
36. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention: Insights From the NCDR Registry.
Motivala AA; Parikh V; Roe M; Dai D; Abbott JD; Prasad A; Mukherjee D
JACC Cardiovasc Interv; 2016 Aug; 9(16):1639-48. PubMed ID: 27539683
[TBL] [Abstract][Full Text] [Related]
37. Determination of the cut-off plasma adiponectin level associated with a lower risk of restenosis in patients with stable angina.
Mito T; Miura S; Iwata A; Morii J; Sugihara M; Ike A; Mori K; Kawamura A; Nishikawa H; Zhang B; Saku K
Coron Artery Dis; 2011 Nov; 22(7):451-7. PubMed ID: 21811155
[TBL] [Abstract][Full Text] [Related]
38. The amount of C1q-adiponectin complex is higher in the serum and the complex localizes to perivascular areas of fat tissues and the intimal-medial layer of blood vessels of coronary artery disease patients.
Hong ES; Lim C; Choi HY; Ku EJ; Kim KM; Moon JH; Lim S; Park KS; Jang HC; Choi SH
Cardiovasc Diabetol; 2015 May; 14():50. PubMed ID: 25956582
[TBL] [Abstract][Full Text] [Related]
39. Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure.
Ohara T; Hashimura K; Asakura M; Ogai A; Amaki M; Hasegawa T; Kanzaki H; Sonoda M; Nishizawa H; Funahashi T; Kitakaze M
J Cardiol; 2011 Sep; 58(2):181-90. PubMed ID: 21824750
[TBL] [Abstract][Full Text] [Related]
40. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
Liang KW; Lee WJ; Lee WL; Ting CT; Sheu WH
Clin Chim Acta; 2009 Jul; 405(1-2):114-8. PubMed ID: 19397903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
